EPGL Stock Updates 08/22/2014 17:30:31 $EPGL EPGL another

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...

Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...

Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...

Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...

Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...

Strong Sales Growth in Q3 for SMCP The latest sales report for SMCP has highlighted a solid growth trajectory in the third quarter. The performance is attributed to robust activities in the America and EMEA regions, showcasing the effectiveness of the company's strategic initiatives. Sales Overview and Highlights In the first nine months of 2025, SMCP achieved impressive...

InflaRx to Participate in Major Investor Conferences In a noteworthy announcement, InflaRx N.V. (Nasdaq: IFRX), a leading biopharmaceutical company specializing in anti-inflammatory therapeutics, is gearing up for participation in two significant investor conferences in September. This engagement comes as the company continues to push boundaries in treating inflammatory...

Rapid7 to Attend Prominent Conference Rapid7, Inc. (NASDAQ:RPD), a frontrunner in threat detection and exposure management, has recently announced its participation in a significant event: the Raymond James TMT and Consumer Conference. This notable conference will take place in New York, providing a platform where industry leaders gather to discuss innovations and...

Theriva Biologics Expands Opportunities with New Offering Theriva Biologics (NYSE American: TOVX), a clinical-stage company focused on developing innovative cancer therapeutics, has recently completed a significant public offering aimed at raising $7.5 million. This initiative is not only a financial step for Theriva but also a strategic move to enhance its research...

Costco's New Board Nominee Costco Wholesale Corporation (NASDAQ: COST) has announced the nomination of Gina Raimondo to its Board of Directors. Raimondo, who has an impressive track record, served as the 40th Secretary of Commerce and held the position of Governor of Rhode Island. Her political career began in 2010 when she was elected as the Treasurer of Rhode Island....